中国实验室技术及装备交易会
   *Home       About Us       Exhibitor       Vistor       Travel & Stay       News       Previous Show       Download       Contact Us   
国药励展展览有限责任公司

China Chemical and Reagent Industry Association



Experimental Technology and Management
China Biotechnology
Chinese Journal of Pharmaceutical Analysis
Chemical Reagent
Acta Pharmaceutica Sinica
Journal of Instrumental Analysis
Life Science Instruments
Zhongguo Yiyao Bao
Medicine Economic News






















MEDICALSURGICALS.COM

China Plans to Invest 200 Million in Improving Drug Standards


  2009-12-18


The State Food and Drug Administration held a regular monthly press conference on September 8. It is learned from the conference that pharmaceutical sector is accelerating the implementation in standards of the National Drug Plan of Action.
CPC Central Committee and State Council have attached great importance to pharmaceutical standards work and treat it as one of the most important livelihood projects. The central financial government invested RMB 100 million in 2008 to enhance the standards of 1000 drugs and plans to invest nearly RMB 200 million in 2009 to support higher standards work, which is unprecedented.
State Food and Drug Administration is accelerating the implementation of perfecting national drug standards action plan in 2009, and has developed detailed plans and arrangements. This standards improvement will focus on the high-risk drugs including injections, national drugs and drugs included in the state's essential drugs list. As for the drugs included in the essential drug list, higher standards will be applied to one by one to ensure the quality of essential drugs and public drug safety; as for national drugs and high-risk injections, in particular, the higher standards of TCM injections, human and capital investment will be increased. It is planned to invest 24.5 million yuan for the upgrade of the standards of national drugs, and 21 million yuan for the upgrade of the standards of traditional Chinese medicine injections. In addition to the strengthening in capital investment, the government guides and encourages enterprises to actively participate in standard upgrade work through various policy measures. As for the drugs that are applied to higher standards on the initiative, the priority will be given to be included in the national pharmacopoeia; as for the drugs whose standards fail to guarantee the quality upon evaluation, they will be excluded step by step using the standard selection mechanism. It is our goal that through a few years of hard work biological products standards will be brought into line with the standards of developed countries, chemicals standards will reach the international standards level, and Chinese medicine quality will be more secure and under control.

                                                                               Source: China Network

  浏览次数:594
1
打印】【关闭
 


中国国际医疗器械博览会 中国国际医疗器械西部博览会 中国国际医疗器械设计与制造技术展览会 全国药品交易会 全国新特药品交易会
中国原料药、中间体、包装、设备交易会 中国国际家庭医疗用品展览会 中国国际医学论坛 中国国际化妆品、个人及家庭护理用品原料及包装设备展览会
2002-2007 国药励展展览有限责任公司 版权所有 网站联系人webmaster@reedsinopharm.com 联系电话010-84556677
备案序号: 京ICP备06050757